COLUF Stock DD Colossus Minerals Inc. 08/07/2014 06:37:40

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
COLUF Colossus Minerals Inc. $COLUF Company Overview

Stock Message Board Recent Posts http://investorshangout.com/search?q=COLUF&am...mp;yt0=Go!

Last Updated: 08/07/2014 06:37:35

Current Price and Quotes
Last Price 0.16
Previous Close 0.16 Open N/A
Daily Range N/A - N/A 52wk Range N/A - 170.00
Volume 12 Dividend N/A
Average Vol (3m) 6,942 Yield N/A




Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Jul 31, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses

Research and Development - - - -
Sales, General and Admin. 23,117 21,400 11,031 9,695
Non-Recurring Items 10,173 8,675 22,292 283
Other - - - 85
Operating Income (33,290) (30,075) (33,323) (10,064)
Income From Continuing Operations

Add'l Income/Expense Items 8,839 2,781 645 106
Earnings Before Interest and Tax (24,451) (27,294) (32,678) (9,958)
Interest Expense 4,683 4,850 10 -
Earnings Before Tax (29,134) (32,144) (32,688) (9,958)
Income Tax 929 - - -
Minority Interest - - - (42)
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (30,063) (32,144) (32,688) (9,916)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (30,063) (32,144) (32,688) (9,916)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (30,063) (32,144) (32,688) (9,916)

Recent News


COLUF Colossus Minerals Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=COLUF&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/COLUF/quote
Stock Chart http://www.otcmarkets.com/stock/COLUF/chart
Company Info http://www.otcmarkets.com/stock/COLUF/company-info
Recent News http://www.otcmarkets.com/stock/COLUF/news
Financials http://www.otcmarkets.com/stock/COLUF/financials
Filings and Disclosure http://www.otcmarkets.com/stock/COLUF/filings
Short Sales http://www.otcmarkets.com/stock/COLUF/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/COLUF/insider-transactions
Research Reports http://www.otcmarkets.com/stock/COLUF/research
Summary http://finance.yahoo.com/q?s=COLUF
Historical Prices http://finance.yahoo.com/q/hp?s=COLUF+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=COLUF
Basic Chart http://finance.yahoo.com/q/bc?s=COLUF+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=COLUF+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=COLUF+Headlines
Press Releases http://finance.yahoo.com/q/p?s=COLUF+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=COLUF+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=COLUF+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=COLUF+Industry
Major Holders http://finance.yahoo.com/q/mh?s=COLUF+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=COLUF+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=COLUF+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=COLUF
Balance Sheet http://finance.yahoo.com/q/bs?s=COLUF
Cash Flow http://finance.yahoo.com/q/cf?s=COLUF+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/COLUF
Market Watch http://www.marketwatch.com/investing/stock/COLUF
Bloomberg http://www.bloomberg.com/quote/COLUF:US
Morningstar http://quotes.morningstar.com/stock/s?t=COLUF
Bussinessweek http://investing.businessweek.com/research/st...cker=COLUF
Barchart http://www.barchart.com/quotes/stocks/COLUF
OTC Short Report http://otcshortreport.com/index.php?index=COLUF
Investopedia http://www.investopedia.com/markets/stocks/COLUF/?wa=0
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 8

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 7

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 10

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 14

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 9

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 11

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 12

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 11

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 14

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading

Top 5 Most Recently Viewed Articles

Replay Sports Cards Revolutionizes the Trading Card Industry

Updated Category News Views 288

Replay Sports Cards Capitalizes on Trading Card Opportunities Trading cards are undergoing a radical transformation; what was once seen as a childhood pastime is now a robust business venture. The trading card market is expected to expand exponentially, with estimated sales skyrocketing from $14.9 billion in 2023 to an incredible $52.1 billion by 2034. This surge speaks...

Continue Reading
Moca Network's AIR Shop Revolutionizes Event Ticketing Experience

Updated Category News Views 159

Moca Network's AIR Shop Revolutionizes Event Ticketing Experience Fans can now enjoy exciting new opportunities as Moca Network introduces AIR Shop Tickets, a remarkable platform that offers over 40 million tickets for concerts, sports, theater performances, and various live events. With this innovation, fans have a unique chance to earn up to 10% back on ticket purchases...

Continue Reading
Cincinnati Children's and MultiCare: Boosting Heart Care Access

Updated Category News Views 204

Big Changes for Pediatric Heart Care in the PNW Ever find yourself stuck between a rock and a hard place when it comes to healthcare options for your kids? I swear, like clockwork, every time I think about the state of pediatric care, it sends me down memory lane—could be the dot-com bust vibes, you know? Anyway, Cincinnati Children's Hospital is teaming up with...

Continue Reading
Immuneering Gains Orphan Drug Status for Groundbreaking Cancer Therapy

Updated Category News Views 117

Immuneering Corporation's Orphan Drug Designation Immuneering Corporation (NASDAQ:IMRX), a pioneering biotechnology firm in the oncology space, is making headlines with the recent designation of its drug candidate, IMM-1-104, as an orphan drug by the U.S. Food and Drug Administration (FDA). This recognition is a crucial step in the development of treatments aimed at rare...

Continue Reading
Applied Optoelectronics Unveils New Employee Equity Grants

Updated Category News Views 203

Applied Optoelectronics Introduces New Equity Grants for Employees In an exciting development, Applied Optoelectronics, Inc. (NASDAQ: AAOI) has announced that its board's Compensation Committee has awarded equity grants to new employees under their inducement plan. This initiative involves granting 11,860 shares of common stock to five new team members, with a specific...

Continue Reading